Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation.

Chelban V, Wilson MP, Warman Chardon J, Vandrovcova J, Zanetti MN, Zamba-Papanicolaou E, Efthymiou S, Pope S, Conte MR, Abis G, Liu YT, Tribollet E, Haridy NA, Botía JA, Ryten M, Nicolaou P, Minaidou A, Christodoulou K, Kernohan KD, Eaton A, Osmond M, Ito Y, Bourque P, Jepson JEC, Bello O, Bremner F, Cordivari C, Reilly MM, Foiani M, Heslegrave A, Zetterberg H, Heales SJR, Wood NW, Rothman JE, Boycott KM, Mills PB, Clayton PT, Houlden H; Care4Rare Canada Consortium and the SYNaPS Study Group.

Ann Neurol. 2019 Aug;86(2):225-240. doi: 10.1002/ana.25524. Epub 2019 Jul 1.

PMID:
31187503
2.

Deregulation of LRSAM1 expression impairs the levels of TSG101, UBE2N, VPS28, MDM2 and EGFR.

Minaidou A, Nicolaou P, Christodoulou K.

PLoS One. 2019 Feb 6;14(2):e0211814. doi: 10.1371/journal.pone.0211814. eCollection 2019.

3.

Composite description based on Salient Contours and Color information for CBIR tasks.

Iakovidou C, Anagnostopoulos N, Lux M, Christodoulou K, Boutalis Y, Chatzichristofis SA.

IEEE Trans Image Process. 2019 Jan 25. doi: 10.1109/TIP.2019.2894281. [Epub ahead of print]

PMID:
30703019
4.

Gene variants of adhesion molecules predispose to MS: A case-control study.

Dardiotis E, Panayiotou E, Siokas V, Aloizou AM, Christodoulou K, Hadjisavvas A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Genet. 2019 Jan 16;5(1):e304. doi: 10.1212/NXG.0000000000000304. eCollection 2019 Feb.

5.

Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset.

Andreou S, Panayiotou E, Michailidou K, Pirpa P, Hadjisavvas A, El Salloukh A, Barnes D, Antoniou A, Agathangelou P, Papastavrou K, Christodoulou K, Tanteles GA, Kyriakides T.

Amyloid. 2018 Dec;25(4):220-226. doi: 10.1080/13506129.2018.1534731. Epub 2018 Dec 20.

PMID:
30572722
6.

Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia.

Malekkou A, Samarani M, Drousiotou A, Votsi C, Sonnino S, Pantzaris M, Chiricozzi E, Zamba-Papanicolaou E, Aureli M, Loberto N, Christodoulou K.

Int J Mol Sci. 2018 Oct 10;19(10). pii: E3099. doi: 10.3390/ijms19103099.

7.

Revealing Clusters of Connected Pathways Through Multisource Data Integration in Huntington's Disease and Spastic Ataxia.

Kakouri AC, Christodoulou CC, Zachariou M, Oulas A, Minadakis G, Demetriou CA, Votsi C, Zamba-Papanicolaou E, Christodoulou K, Spyrou GM.

IEEE J Biomed Health Inform. 2019 Jan;23(1):26-37. doi: 10.1109/JBHI.2018.2865569. Epub 2018 Aug 30.

PMID:
30176611
8.

LRSAM1 Depletion Affects Neuroblastoma SH-SY5Y Cell Growth and Morphology: The LRSAM1 c.2047-1G>A Loss-of-Function Variant Fails to Rescue The Phenotype.

Minaidou A, Nicolaou P, Christodoulou K.

Cell J. 2018 Oct;20(3):340-347. doi: 10.22074/cellj.2018.5352. Epub 2018 May 15.

9.

Quantification of dysarthrοphonia in a Cypriot family with autosomal recessive hereditary spastic paraplegia associated with a homozygous SPG11 mutation.

Konstantopoulos K, Zamba-Papanicolaou E, Christodoulou K.

Neurol Sci. 2018 Sep;39(9):1547-1550. doi: 10.1007/s10072-018-3453-8. Epub 2018 May 26.

PMID:
29804168
10.

Epidemiology of Huntington disease in Cyprus: A 20-year retrospective study.

Demetriou CA, Heraclides A, Salafori C, Tanteles GA, Christodoulou K, Christou Y, Zamba-Papanicolaou E.

Clin Genet. 2018 Mar;93(3):656-664. doi: 10.1111/cge.13168. Epub 2018 Feb 8.

PMID:
29105741
11.

Gene variants of adhesion molecules act as modifiers of disease severity in MS.

Dardiotis E, Panayiotou E, Provatas A, Christodoulou K, Hadjisavvas A, Antoniades A, Lourbopoulos A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 24;4(4):e350. doi: 10.1212/NXI.0000000000000350. eCollection 2017 Jul.

12.

Type 2 Diabetes Susceptibility in the Greek-Cypriot Population: Replication of Associations with TCF7L2, FTO, HHEX, SLC30A8 and IGF2BP2 Polymorphisms.

Votsi C, Toufexis C, Michailidou K, Antoniades A, Skordis N, Karaolis M, Pattichis CS, Christodoulou K.

Genes (Basel). 2017 Jan 6;8(1). pii: E16. doi: 10.3390/genes8010016.

13.

Genomic and genetic studies of systemic sclerosis: A systematic review.

Chairta P, Nicolaou P, Christodoulou K.

Hum Immunol. 2017 Feb;78(2):153-165. doi: 10.1016/j.humimm.2016.10.017. Epub 2016 Oct 29. Review.

PMID:
27984087
14.

Semi-Interpenetrating Polymer Networks with Predefined Architecture for Metal Ion Fluorescence Monitoring.

Christodoulou K, Leontidis E, Achilleos M, Polydorou C, Krasia-Christoforou T.

Polymers (Basel). 2016 Nov 29;8(12). pii: E411. doi: 10.3390/polym8120411.

15.

Kuopio University Hospital Job Satisfaction Scale (KUHJSS): its validation in the Greek language.

Sapountzi-Krepia D, Zyga S, Prezerakos P, Malliarou M, Efstathiou C, Christodoulou K, Charalambous G.

J Nurs Manag. 2017 Jan;25(1):13-21. doi: 10.1111/jonm.12418. Epub 2016 Aug 23.

PMID:
27550236
16.

Television-based health promotion in general practice waiting rooms in London: a cross-sectional study evaluating patients' knowledge and intentions to access dental services.

Jawad M, Ingram S, Choudhury I, Airebamen A, Christodoulou K, Wilson Sharma A.

BMC Oral Health. 2016 Jul 20;17(1):24. doi: 10.1186/s12903-016-0252-6.

17.

Genetic findings of Cypriot spinal muscular atrophy patients.

Theodorou L, Nicolaou P, Koutsou P, Georghiou A, Anastasiadou V, Tanteles G, Kyriakides T, Zamba-Papanicolaou E, Christodoulou K.

Neurol Sci. 2015 Oct;36(10):1829-34. doi: 10.1007/s10072-015-2263-5. Epub 2015 May 28.

PMID:
26017350
18.

A novel GBA2 gene missense mutation in spastic ataxia.

Votsi C, Zamba-Papanicolaou E, Middleton LT, Pantzaris M, Christodoulou K.

Ann Hum Genet. 2014 Jan;78(1):13-22. doi: 10.1111/ahg.12045. Epub 2013 Nov 20.

19.

Friedreich's ataxia and other hereditary ataxias in Greece: an 18-year perspective.

Koutsis G, Kladi A, Karadima G, Houlden H, Wood NW, Christodoulou K, Panas M.

J Neurol Sci. 2014 Jan 15;336(1-2):87-92. doi: 10.1016/j.jns.2013.10.012. Epub 2013 Oct 16.

PMID:
24209901
20.

Commissioning: tactics for delivering a lifesaving message.

Ingram S, Bedi S, Choudhury I, Christodoulou K, Wilson A.

Health Serv J. 2013 Mar 28;123(6345):21-3. No abstract available.

PMID:
23898760
21.

Investigation of SCA10 in the Cypriot population: further exclusion of SCA dynamic repeat mutations.

Votsi C, Zamba-Papanicolaou E, Georghiou A, Kyriakides T, Papacostas S, Kleopa KA, Pantzaris M, Christodoulou K.

J Neurol Sci. 2012 Dec 15;323(1-2):154-7. doi: 10.1016/j.jns.2012.09.006. Epub 2012 Sep 29.

PMID:
23026538
22.

A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease.

Nicolaou P, Cianchetti C, Minaidou A, Marrosu G, Zamba-Papanicolaou E, Middleton L, Christodoulou K.

Eur J Hum Genet. 2013 Feb;21(2):190-4. doi: 10.1038/ejhg.2012.146. Epub 2012 Jul 11.

23.

Helicobacter pylori infection and Parkinson's disease: apoptosis as an underlying common contributor.

Kountouras J, Zavos C, Polyzos SA, Deretzi G, Vardaka E, Giartza-Taxidou E, Katsinelos P, Rapti E, Chatzopoulos D, Tzilves D, Stergiopoulos C, Christodoulou K.

Eur J Neurol. 2012 Jun;19(6):e56. doi: 10.1111/j.1468-1331.2012.03695.x. No abstract available.

PMID:
22577753
24.

Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes.

Christodoulou K, Wiskin AE, Gibson J, Tapper W, Willis C, Afzal NA, Upstill-Goddard R, Holloway JW, Simpson MA, Beattie RM, Collins A, Ennis S.

Gut. 2013 Jul;62(7):977-84. doi: 10.1136/gutjnl-2011-301833. Epub 2012 Apr 28.

25.

Huntington's disease in Greece: the experience of 14 years.

Panas M, Karadima G, Vassos E, Kalfakis N, Kladi A, Christodoulou K, Vassilopoulos D.

Clin Genet. 2011 Dec;80(6):586-90. doi: 10.1111/j.1399-0004.2010.01603.x. Epub 2010 Dec 20.

PMID:
21166788
26.

Charcot-Marie-Tooth disease in Cyprus: epidemiological, clinical and genetic characteristics.

Nicolaou P, Zamba-Papanicolaou E, Koutsou P, Kleopa KA, Georghiou A, Hadjigeorgiou G, Papadimitriou A, Kyriakides T, Christodoulou K.

Neuroepidemiology. 2010;35(3):171-7. doi: 10.1159/000314351. Epub 2010 Jun 23.

PMID:
20571287
27.

EMQN Best Practice Guidelines for molecular genetic testing of SCAs.

Sequeiros J, Martindale J, Seneca S, Giunti P, Kämäräinen O, Volpini V, Weirich H, Christodoulou K, Bazak N, Sinke R, Sulek-Piatkowska A, Garcia-Planells J, Davis M, Frontali M, Hämäläinen P, Wieczorek S, Zühlke C, Saraiva-Pereira ML, Warner J, Leguern E, Thonney F, Quintáns Castro B, Jonasson J, Storm K, Andersson A, Ravani A, Correia L, Silveira I, Alonso I, Martins C, Pinto Basto J, Coutinho P, Perdigão A, Barton D, Davis M; European Molecular Quality Genetics Network.

Eur J Hum Genet. 2010 Nov;18(11):1173-6. doi: 10.1038/ejhg.2010.8. Epub 2010 Feb 24. No abstract available. Erratum in: Eur J Hum Genet. 2010 Nov;18(11):1176-7. multiple author names added.

28.

Absence of aprataxin gene mutations in a Greek cohort with sporadic early onset ataxia and normal GAA triplets in frataxin gene.

Daiou C, Christodoulou K, Xiromerisiou G, Panas M, Dardiotis E, Kladi A, Speletas M, Ntaios G, Papadimitriou A, Germenis A, Hadjigeorgiou GM.

Neurol Sci. 2010 Jun;31(3):393-7. doi: 10.1007/s10072-009-0201-0. Epub 2009 Dec 2.

PMID:
19953284
29.

High frequency of Friedreich's ataxia carriers in the Paphos district of Cyprus.

Zamba-Papanicolaou E, Koutsou P, Daiou C, Gaglia E, Georghiou A, Christodoulou K.

Acta Myol. 2009 Jul;28(1):24-6.

30.

Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.

Dardiotis E, Koutsou P, Zamba-Papanicolaou E, Vonta I, Hadjivassiliou M, Hadjigeorgiou G, Cariolou M, Christodoulou K, Kyriakides T.

J Neurol Sci. 2009 Sep 15;284(1-2):158-62. doi: 10.1016/j.jns.2009.05.018. Epub 2009 Jun 3.

PMID:
19493541
31.

Familial asymmetric distal upper limb amyotrophy (Hirayama disease): report of a Greek family.

Andreadou E, Christodoulou K, Manta P, Karandreas N, Loukaidis P, Sfagos C, Vassilopoulos D.

Neurologist. 2009 May;15(3):156-60. doi: 10.1097/NRL.0b013e31818d6717.

PMID:
19430273
32.

X-linked cataract and Nance-Horan syndrome are allelic disorders.

Coccia M, Brooks SP, Webb TR, Christodoulou K, Wozniak IO, Murday V, Balicki M, Yee HA, Wangensteen T, Riise R, Saggar AK, Park SM, Kanuga N, Francis PJ, Maher ER, Moore AT, Russell-Eggitt IM, Hardcastle AJ.

Hum Mol Genet. 2009 Jul 15;18(14):2643-55. doi: 10.1093/hmg/ddp206. Epub 2009 May 4.

33.

Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus.

Dardiotis E, Koutsou P, Papanicolaou EZ, Vonta I, Kladi A, Vassilopoulos D, Hadjigeorgiou G, Christodoulou K, Kyriakides T.

Amyloid. 2009 Mar;16(1):32-7. doi: 10.1080/13506120802676948.

PMID:
19291512
34.

A novel ALS2 splice-site mutation in a Cypriot juvenile-onset primary lateral sclerosis family.

Mintchev N, Zamba-Papanicolaou E, Kleopa KA, Christodoulou K.

Neurology. 2009 Jan 6;72(1):28-32. doi: 10.1212/01.wnl.0000338530.77394.60.

PMID:
19122027
35.

Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit.

Yoon G, Westmacott R, Macmillan L, Quercia N, Koutsou P, Georghiou A, Christodoulou K, Banwell B.

BMJ Case Rep. 2009;2009. pii: bcr08.2008.0688. doi: 10.1136/bcr.08.2008.0688. Epub 2009 Feb 2.

36.

Management of gastrointestinal bezoars: an analysis of 23 cases.

Koulas SG, Zikos N, Charalampous C, Christodoulou K, Sakkas L, Katsamakis N.

Int Surg. 2008 Mar-Apr;93(2):95-8.

PMID:
18998288
37.

A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.

Nicolaou P, Georghiou A, Votsi C, Middleton LT, Zamba-Papanicolaou E, Christodoulou K.

BMC Med Genet. 2008 Apr 14;9:28. doi: 10.1186/1471-2350-9-28.

38.

Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit.

Yoon G, Westmacott R, MacMillan L, Quercia N, Koutsou P, Georghiou A, Christodoulou K, Banwell B.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):234-6. doi: 10.1136/jnnp.2007.127233. No abstract available.

PMID:
18202221
39.

Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.

Zoumpopoulou G, Foligne B, Christodoulou K, Grangette C, Pot B, Tsakalidou E.

Int J Food Microbiol. 2008 Jan 15;121(1):18-26. Epub 2007 Nov 6.

PMID:
18077037
40.

Auditory nerve is affected in one of two different point mutations of the neurofilament light gene.

Butinar D, Starr A, Zidar J, Koutsou P, Christodoulou K.

Clin Neurophysiol. 2008 Feb;119(2):367-75. Epub 2007 Nov 26.

41.

Ileocolic intussusception due to endometriosis.

Koutsourelakis I, Markakis H, Koulas S, Mparmpantonakis N, Perraki E, Christodoulou K.

JSLS. 2007 Jan-Mar;11(1):131-5.

42.

Malignant mutation in the lamin A/C gene causing progressive conduction system disease and early sudden death in a family with mild form of limb-girdle muscular dystrophy.

Antoniades L, Eftychiou C, Kyriakides T, Christodoulou K, Katritsis DG.

J Interv Card Electrophysiol. 2007 Jun;19(1):1-7. Epub 2007 Jun 29.

PMID:
17605093
43.

A novel GDAP1 mutation 439delA is associated with autosomal recessive CMT disease.

Georgiou DM, Nicolaou P, Chitayat D, Koutsou P, Babul-Hirji R, Vajsar J, Murphy J, Christodoulou K.

Can J Neurol Sci. 2006 Aug;33(3):311-6.

PMID:
17001820
44.

Absence of linkage to chromosomes 6q and 16p in a Greek population with knee osteoarthritis.

Tsezou A, Karachalios T, Fytili P, Giannatou E, Christodoulou K, Hadjigeorgiou GM, Malizos KN.

J Orthop Res. 2006 Sep;24(9):1900-5.

45.

The cypriot and Iranian National Mutation Frequency Databases.

Kleanthous M, Patsalis PC, Drousiotou A, Motazacker M, Christodoulou K, Cariolou M, Baysal E, Khrizi K, Moghimi B, Pourfarzad F, van Baal S, Deltas C, Najmabadi H, Patrinos GP.

Hum Mutat. 2006 Jun;27(6):598-9.

PMID:
16705699
46.

Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X.

Kleopa KA, Zamba-Papanicolaou E, Alevra X, Nicolaou P, Georgiou DM, Hadjisavvas A, Kyriakides T, Christodoulou K.

Neurology. 2006 Feb 14;66(3):396-402.

PMID:
16476939
47.

Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.

Sivakumar K, Kyriakides T, Puls I, Nicholson GA, Funalot B, Antonellis A, Sambuughin N, Christodoulou K, Beggs JL, Zamba-Papanicolaou E, Ionasescu V, Dalakas MC, Green ED, Fischbeck KH, Goldfarb LG.

Brain. 2005 Oct;128(Pt 10):2304-14. Epub 2005 Jul 13.

PMID:
16014653
48.

High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial.

Katsinelos P, Kountouras J, Chatzis J, Christodoulou K, Paroutoglou G, Mimidis K, Beltsis A, Zavos C.

Gastrointest Endosc. 2005 Mar;61(3):407-15.

PMID:
15758912
49.

Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.

Nanas JN, Papazoglou PP, Terrovitis JV, Kanakakis J, Dalianis A, Tsolakis E, Tsagalou EP, Agrios N, Christodoulou K, Anastasiou-Nana MI.

Am J Cardiol. 2004 Nov 15;94(10):1329-32.

PMID:
15541261
50.

A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes.

Kleopa KA, Georgiou DM, Nicolaou P, Koutsou P, Papathanasiou E, Kyriakides T, Christodoulou K.

Neurogenetics. 2004 Sep;5(3):171-5. Epub 2004 Jun 17.

PMID:
15205993

Supplemental Content

Loading ...
Support Center